Lifeforce and Toku Partner to Use AI Retinal Scans for Health Insights
Lifeforce and Toku have announced a nationwide partnership to integrate AI retinal scans with the world's largest longevity medicine platform. Announced in a press release, this collaboration aims to transform routine eye exams into opportunities for early health insights and proactive intervention.
The partnership will leverage Toku's BioAge™ wellness product and its forthcoming CLAiR™ technology, which has received the FDA Breakthrough Device designation. CLAiR™ is designed to assess cardiovascular risk using retinal imaging and AI, with anticipated FDA approval in 2026.
Through this collaboration, individuals who undergo a BioAge analysis will be connected to Lifeforce's comprehensive longevity platform. This platform offers at-home diagnostics, access to board-certified longevity physicians, and personalized health protocols, enabling participants to take data-driven steps toward extending their healthspan.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology Researchers Oct 30 Surveys Find Widespread AI Chatbot Use Among Teens and Tweens Oct 30 Widow Sues OpenAI and Luka Over Husband's SuicideLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Boehringer Ingelheim and Microsoft to Study Digital Patient Twins
MEDITECH and Lifemed AI Partner on Claims Automation
Taiwanese Health Technology Groups Test US Market in Dallas
Daily AI Brief: the AI news that matters, in your inbox.